Literature DB >> 3878239

Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.

D H Kono, M Ogasawara, R B Effros, M S Park, R L Waldord, D T Yu.   

Abstract

A monoclonal antibody, Ye-1, was generated by immunizing BALB/c mice with Yersinia enterocolitica. This antibody also reacted with all of 12 B27 positive lymphoblastoid cell lines, but only four of 31 B27 negative ones. Three of the four reactive B27 negative cell lines were B7 positive. A B27 positive cell line which has lost the B27 expression because of experimentally-induced mutation became unreactive with the Ye-1. These findings support the possibility that there is cross-reactivity between HLA-B27 antigens and Y. enterocolitica.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878239      PMCID: PMC1577260     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

3.  Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls.

Authors:  F C Grumet; B M Fendly; E G Engleman
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

4.  HLA loss variants of a B27+ lymphoblastoid cell line: genetic and cellular characterization.

Authors:  J A Nicklas; Y Miyachi; J D Taurog; S L Wee; L K Chen; F C Grumet; F H Bach
Journal:  Hum Immunol       Date:  1984-09       Impact factor: 2.850

5.  Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia.

Authors:  C G van Bohemen; F C Grumet; H C Zanen
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

Review 6.  Reiter's syndrome and reactive arthritis in perspective.

Authors:  A Keat
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  Lymphocytotoxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies: patient and family studies.

Authors:  J Edmonds; D Macauley; A Tyndall; M Liew; K Alexander; A Geczy; H Bashir
Journal:  Arthritis Rheum       Date:  1981-01

8.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

9.  In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA-B27 positive individuals.

Authors:  M B Brenner; S Kobayashi; C W Wiesenhutter; A K Huberman; P Bales; D T Yu
Journal:  Arthritis Rheum       Date:  1984-03

10.  Purification of the H-2Kk molecule of the murine major histocompatibility complex.

Authors:  S H Herrmann; M F Mescher
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

  10 in total
  15 in total

1.  Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies.

Authors:  A Ebringer; M Ghuloom
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

2.  HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions.

Authors:  A F Geczy; J K Prendergast; J S Sullivan; L I Upfold; L E McGuigan; H V Bashir; M Prendergast; J P Edmonds
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

3.  HLA-B27 and the causes of arthritis: does molecular biology help?

Authors:  J R Archer; V R Winrow
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

Review 4.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

5.  Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.

Authors:  N Tsuchiya; G Husby; R C Williams; H Stieglitz; P E Lipsky; R D Inman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  IgA antibody response to klebsiella in ankylosing spondylitis measured by immunoblotting.

Authors:  F Shodjai-Moradi; A Ebringer; I Abuljadayel
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

7.  Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.

Authors:  D D de Vries; A J Dekker-Saeys; E Gyodi; U Bohm; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

8.  Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 9.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

10.  Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella pneumoniae.

Authors:  M Ogasawara; D H Kono; D T Yu
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.